UK Markets close in 1 hr 44 mins

Genmab A/S (GNMSF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
290.75+15.50 (+5.63%)
As of 03:49PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.74
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 3500.92
52-week low 3274.93
50-day moving average 3344.45
200-day moving average 3393.39

Share statistics

Avg vol (3-month) 3698
Avg vol (10-day) 3900
Shares outstanding 565.42M
Implied shares outstanding 6N/A
Float 8129.36M
% held by insiders 14.62%
% held by institutions 150.96%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in DKK.

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sept 2021

Profitability

Profit margin 36.34%
Operating margin (ttm)39.43%

Management effectiveness

Return on assets (ttm)8.56%
Return on equity (ttm)14.45%

Income statement

Revenue (ttm)7.91B
Revenue per share (ttm)120.91
Quarterly revenue growth (yoy)34.00%
Gross profit (ttm)10.11B
EBITDA 3.42B
Net income avi to common (ttm)2.87B
Diluted EPS (ttm)6.61
Quarterly earnings growth (yoy)67.90%

Balance sheet

Total cash (mrq)18.74B
Total cash per share (mrq)143.32
Total debt (mrq)437M
Total debt/equity (mrq)2.05
Current ratio (mrq)12.00
Book value per share (mrq)325.51

Cash flow statement

Operating cash flow (ttm)1.19B
Levered free cash flow (ttm)633.63M